All Access Articles |
- Arrivent BioPharma Presents Exciting Cancer Research at AACR Meeting | 2026-03-18 | UNITED STATES
- ArriVent BioPharma Developing Cancer Medicines | 2025-11-10 | PHARMACEUTICAL
- ArriVent BioPharma Prices Public Offering at $19.50 per Share | 2025-07-03 | UNITED STATES
- ArriVent BioPharma Appoints Dr. Merdad Parsey to Board | 2025-04-28 | UNITED STATES
- ArriVent BioPharma Reports Strong Financial Results | 2025-03-03 | UNITED STATES